Approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended on 30th June, 2026, along with year-to-date figures for the period from 1st April, 2026, to 30th ....

Date: 29th July, 2026 BSE Limited, Dept. of Corporate Services, BSE Limited, P. J. Tower, Dalal Street, Fort, Mumbai-400001, Maharashtra, India Scrip Code: 541735 ISIN: INE299W01022 Subject: Outcome of Board of Directors Meeting of Vivanta Industries Limited (“the Company”) Dear Sir/Madam, Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), we wish to inform you that the Board of Directors of the Company at its meeting held today, i.e. Wednesday, 29th July, 2026, at the Registered Office of the Company, has inter alia considered and approved the following businesses: 1. Approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended on 30th June, 2026, along with year-to-date figures for the period from 1st April, 2026, to 30th June, 2026 together with the Limited Review Report (Annexure –A). 2. The Board took note of the disclosure of interest received from the Directors pursuant to Section 184 of the Companies Act, 2013 and the intimation of disqualification under Section 164 of the Companies Act, 2013. 3. The Board took note of the declarations received from the Independent Directors confirming that they meet the criteria of independence as prescribed under Section 149(7) of the Companies Act, 2013 and Regulation 25(8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 4. The Board took note of issuance of Duplicate Share Certificate(s) under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 to one shareholder named as Mr. Rajesh Bhanji Lakum in lieu of the original share certificate(s) reported as lost/misplaced by the shareholders. 5. The Board also took note of the execution of a Certain Business Collaboration agreements with Qness Pharmaceuticals, a proprietorship concern with the manufacture, supply, branding and marketing of pharmaceutical and allied products. 6. The Board took note of the Corporate Governance Report for the quarter ended 30th June, 2026, pursuant to Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 7. The Board took note of the e-form DPT-3 (Return of Deposits) for the financial year ended 31st March, 2026, to be filed with the Registrar of Companies. 8. The Board considered and approved the authorisation of designated signatories to open a Trading Account and Demat Account with Motilal Oswal Financial Services Limited (MOFSL) on behalf of the Company. 9. The Board considered and approved the authorisation of Mr. H.A. Parikh, Managing Director, Mr. Jainil Bhatt, Director and Mr. Devang Shah, Company Secretary & Compliance Officer, to severally sign, execute and file statutory forms, returns, applications, disclosures and other documents with various statutory and regulatory authorities on behalf of the Company, until the conclusion of the next Annual General Meeting or until modified or rescinded by the Board, whichever is earlier. The meeting of the Board of Directors of the Company commenced at 04:00 P.M. and concluded at 04:30 P.M. You are requested to kindly take the same on record and acknowledge. FOR, VIVANTA INDUSTRIES LIMITED H. A. PARIKH MANAGING DIRECTOR DIN: 00027820 Encl: As above